Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 2
1959 2
1960 6
1961 4
1962 3
1963 2
1964 2
1965 1
1966 3
1967 4
1968 3
1970 3
1971 2
1975 1
1980 1
1981 1
1982 2
1983 1
1984 1
1985 2
1986 2
1987 3
1988 3
1989 3
1990 2
1992 1
1993 1
1996 3
1997 2
1998 3
1999 2
2000 3
2001 3
2002 1
2003 3
2004 5
2005 2
2006 1
2007 6
2008 5
2009 2
2010 4
2011 5
2012 5
2013 6
2014 9
2015 10
2016 9
2017 11
2018 10
2019 13
2020 8
2021 19
2022 5
2023 15
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Results by year

Filters applied: . Clear all
Page 1
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. Humbert M, et al. Among authors: meszaros g. Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237. Eur Heart J. 2022. PMID: 36017548 No abstract available.
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. Humbert M, et al. Among authors: meszaros g. Eur Respir J. 2023 Jan 6;61(1):2200879. doi: 10.1183/13993003.00879-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36028254 No abstract available.
ERS statement on chronic thromboembolic pulmonary hypertension.
Delcroix M, Torbicki A, Gopalan D, Sitbon O, Klok FA, Lang I, Jenkins D, Kim NH, Humbert M, Jais X, Vonk Noordegraaf A, Pepke-Zaba J, Brénot P, Dorfmuller P, Fadel E, Ghofrani HA, Hoeper MM, Jansa P, Madani M, Matsubara H, Ogo T, Grünig E, D'Armini A, Galie N, Meyer B, Corkery P, Meszaros G, Mayer E, Simonneau G. Delcroix M, et al. Among authors: meszaros g. Eur Respir J. 2021 Jun 17;57(6):2002828. doi: 10.1183/13993003.02828-2020. Print 2021 Jun. Eur Respir J. 2021. PMID: 33334946 Free article. Review.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I).
Morand EF, Vital EM, Petri M, van Vollenhoven R, Wallace DJ, Mosca M, Furie RA, Silk ME, Dickson CL, Meszaros G, Jia B, Crowe B, de la Torre I, Dörner T. Morand EF, et al. Among authors: meszaros g. Lancet. 2023 Mar 25;401(10381):1001-1010. doi: 10.1016/S0140-6736(22)02607-1. Epub 2023 Feb 24. Lancet. 2023. PMID: 36848918 Clinical Trial.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II).
Petri M, Bruce IN, Dörner T, Tanaka Y, Morand EF, Kalunian KC, Cardiel MH, Silk ME, Dickson CL, Meszaros G, Zhang L, Jia B, Zhao Y, McVeigh CJ, Mosca M. Petri M, et al. Among authors: meszaros g. Lancet. 2023 Mar 25;401(10381):1011-1019. doi: 10.1016/S0140-6736(22)02546-6. Epub 2023 Feb 24. Lancet. 2023. PMID: 36848919 Clinical Trial.
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Ramanan AV, Quartier P, Okamoto N, Foeldvari I, Spindler A, Fingerhutová Š, Antón J, Wang Z, Meszaros G, Araújo J, Liao R, Keller S, Brunner HI, Ruperto N; JUVE-BASIS investigators; Paediatric Rheumatology International Trials Organisation. Ramanan AV, et al. Among authors: meszaros g. Lancet. 2023 Aug 12;402(10401):555-570. doi: 10.1016/S0140-6736(23)00921-2. Epub 2023 Jul 6. Lancet. 2023. PMID: 37423231 Clinical Trial.
CaMK1D signalling in AgRP neurons promotes ghrelin-mediated food intake.
Vivot K, Meszaros G, Pangou E, Zhang Z, Qu M, Erbs E, Yeghiazaryan G, Quiñones M, Grandgirard E, Schneider A, Clauss-Creusot E, Charlet A, Faour M, Martin C, Berditchevski F, Sumara I, Luquet S, Kloppenburg P, Nogueiras R, Ricci R. Vivot K, et al. Among authors: meszaros g. Nat Metab. 2023 Jun;5(6):1045-1058. doi: 10.1038/s42255-023-00814-x. Epub 2023 Jun 5. Nat Metab. 2023. PMID: 37277610
A humán papillomavírus okozta megbetegedések, megelőzésük lehetőségei és ennek népegészségügyi előnyei.
Kásler M, Ács N, Bata Z, Dankó D, Hernádi Z, Kálmán M, Kornya L, Kovács J, Mészáros G, Molnár MP, Mór Z, Novák Z, Sobel G, Szentirmay Z, Takács L, Tisza T. Kásler M, et al. Among authors: meszaros g. Orv Hetil. 2012 Dec 15;153 Suppl 4:1-39. doi: 10.1556/650.2012.0004. Orv Hetil. 2012. PMID: 26686555 Hungarian. No abstract available.
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
Aktaa S, Gale CP, Brida M, Giannakoulas G, Kovacs G, Adir Y, Benza RL, Böhm M, Coats A, D'Alto M, Escribano-Subias P, Ferrari P, Galiè N, Gibbs JSR, Gin-Sing W, Hoeper MM, Humbert M, Lang IM, Maron BA, Meszaros G, Vonk Noordegraaf A, Price LC, Pepke-Zaba J, Rådegran G, Reis A, Sitbon O, Torbicki A, Ulrich S, Rosenkranz S, Delcroix M. Aktaa S, et al. Among authors: meszaros g. Eur J Heart Fail. 2023 Apr;25(4):469-477. doi: 10.1002/ejhf.2830. Epub 2023 Apr 4. Eur J Heart Fail. 2023. PMID: 36924171 Review.
[2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. Humbert M, et al. Among authors: meszaros g. G Ital Cardiol (Rome). 2023 Apr;24(4 Suppl 1):e1-e116. doi: 10.1714/4014.39906. G Ital Cardiol (Rome). 2023. PMID: 36995376 Italian. No abstract available.
222 results